Variant report
Variant | esv3464821 |
---|---|
Chromosome Location | chr4:16153305-16154381 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:16146240..16148826-chr4:16152281..16154306,2 | MCF-7 | breast: | |
2 | chr4:16152453..16154569-chr4:16162351..16164254,2 | K562 | blood: | |
3 | chr4:16151157..16153804-chr4:16155728..16157326,2 | K562 | blood: | |
4 | chr4:16150924..16154971-chr4:16155826..16158678,3 | K562 | blood: | |
5 | chr4:16152012..16153677-chr4:16157238..16159911,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6822916 | chr4:16153345-16153346 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs528162568 | chr4:16153376-16153377 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547908404 | chr4:16153401-16153402 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568035542 | chr4:16153409-16153410 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530757813 | chr4:16153410-16153411 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550461080 | chr4:16153422-16153423 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113047985 | chr4:16153426-16153427 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539263158 | chr4:16153428-16153429 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371754641 | chr4:16153466-16153467 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs118133642 | chr4:16153469-16153470 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535102297 | chr4:16153496-16153497 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552260878 | chr4:16153519-16153520 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554706252 | chr4:16153520-16153521 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574883712 | chr4:16153579-16153580 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543792784 | chr4:16153601-16153602 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557697763 | chr4:16153736-16153737 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577579774 | chr4:16153737-16153738 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546105415 | chr4:16153766-16153767 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577013257 | chr4:16153775-16153776 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559877589 | chr4:16153791-16153792 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148031409 | chr4:16153812-16153813 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11724467 | chr4:16153887-16153888 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs112525089 | chr4:16153931-16153932 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530431884 | chr4:16153946-16153947 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550124957 | chr4:16153955-16153956 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564061431 | chr4:16153963-16153964 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17478607 | chr4:16154006-16154007 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs35497470 | chr4:16154022-16154023 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546511879 | chr4:16154094-16154095 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377014811 | chr4:16154138-16154139 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566649812 | chr4:16154209-16154210 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77550400 | chr4:16154250-16154251 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548665847 | chr4:16154263-16154264 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2872215 | chr4:16154320-16154321 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568527252 | chr4:16154361-16154362 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111662106 | chr4:16154362-16154363 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:16150200-16160800 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr4:16150800-16166600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr4:16151600-16158000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr4:16152000-16161600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr4:16152000-16163800 | Weak transcription | Thymus | Thymus |
6 | chr4:16152400-16154400 | Strong transcription | Primary T cells from cord blood | blood |
7 | chr4:16152800-16159800 | Weak transcription | Fetal Muscle Trunk | muscle |
8 | chr4:16153000-16163600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
9 | chr4:16153000-16164400 | Weak transcription | NH-A | brain |
10 | chr4:16153200-16165200 | Weak transcription | HSMM | muscle |
11 | chr4:16153400-16157200 | Weak transcription | Brain Cingulate Gyrus | brain |
12 | chr4:16153600-16153800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr4:16153600-16165600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
14 | chr4:16154000-16159600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr4:16154200-16154400 | Enhancers | Primary neutrophils fromperipheralblood | blood |